• BaumGeist
    link
    fedilink
    arrow-up
    4
    ·
    9 months ago

    Here’s the journal article itself

    This whole thing stinks of advertising. They use a sample size of 24 people. The results are underwhelming: “Each disease cohort concordantly demonstrated increases in the NAD+/NADH ratio but did not reach significance individually” (“when we massaged the numbers, the result we wanted popped out”). Looking at the graphs, it looks like the upper half (highest baselines) of the patients worsened over the 12 week study.

    My favorite lines?

    “The objective of the Phase 2 REPAIR-MS and REPAIR-PD clinical trials was to investigate the effects of CNM-Au8” and “CNM-Au8® is a suspension of faceted, clean-surfaced gold nanocrystals” and course:

    “Clene Nanomedicine, Inc., funded this study.”